CoChat

Carvedilol as a potential novel agent for the treatment of Alzheimer's disease

Open access
Wang, Jun, Ono, Kenjiro, Dickstein, Dara L., Arrieta-Cruz, Isabel, Zhao, Wei, Qian, Xianjuan, Lamparello, Ashley, Subnani, Rakesh, Ferruzzi, Mario, Pavlides, Constantine, Ho, Lap, Hof, Patrick R., Teplow, David B., Pasinetti, Giulio M. · 2011 · Neurobiology of Aging
Cited by 73

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Oligomeric β-amyloid (Aβ) has recently been linked to synaptic plasticity deficits, which play a major role in progressive cognitive decline in Alzheimer’s disease (AD). Here we present evidence that chronic oral administration of carvedilol, a nonselective β-adrenergic receptor blocker, significantly attenuates brain oligomeric Aβ content and cognitive deterioration in two independent AD mouse models. We found that carvedilol treatment significantly improved neuronal transmission, and that this improvement was associated with the maintenance of number of the less stable “learning” thin spines in the brains of AD mice. Our novel observation that carvedilol interferes with the neuropathologic, biochemical and electrophysiological mechanisms underlying cognitive deterioration in AD supports the potential development of carvedilol as a treatment for AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2010.05.004

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 17 references

Cited by

See all 73

Metadata

Authors
Wang, J., Ono, K., Dickstein, D. L., Arrieta-Cruz, I., Zhao, W., Qian, X., Lamparello, A., Subnani, R., Ferruzzi, M., Pavlides, C., Ho, L., Hof, P. R., Teplow, D. B., & Pasinetti, G. M.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2011-12
Volume
32
Issue
12
Pages
2321.e1-2321.e12
ISSN
0197-4580 (ISSN-L)
OpenAlex
W1982420401
Cited by
73
References
17
FWCI
2.85
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Carvedilol as a potential novel agent for the treatment of Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2010.05.004
The paper
Wang, J., Ono, K., Dickstein, D. L., Arrieta-Cruz, I., Zhao, W., Qian, X., Lamparello, A., Subnani, R., Ferruzzi, M., Pavlides, C., Ho, L., Hof, P. R., Teplow, D. B., & Pasinetti, G. M. (2011). Carvedilol as a potential novel agent for the treatment of Alzheimer's disease. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2010.05.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.